Advertisement
Screener

Opus Genetics, Inc. (IRD) Other

Opus Genetics, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2024-08-13: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · OCUP · NASDAQ.
  • 2024-05-10: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · OCUP · NASDAQ.
  • 2024-03-08: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · OCUP · NASDAQ.
  • 2023-11-13: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · OCUP · NASDAQ.
FiledFormItemAs filed
2024-08-1310-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2024-05-1010-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2024-03-0810-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2023-11-1310-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2023-08-1110-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2023-05-1510-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2023-03-3010-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2022-11-0410-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2022-08-1210-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2022-05-1310-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2022-03-2410-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2021-11-1210-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2021-08-1210-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · OCUP · NASDAQ
2020-10-2910-QStock registered under Section 12(b)Common Stock, $.0001 par value · REXN · NASDAQ
2020-08-1410-QStock registered under Section 12(b)Common Stock, $.0001 par value · REXN · NASDAQ
2018-11-0210-QSmaller reporting companyNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63